Fig. 3From: The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysisa. Subgroup analysis of the use of a single antiplatelet agent or two antiplatelet agents and the risk of stroke in haemodialysis patients in all 9 studies; b. Subgroup analysis of the use of a single antiplatelet agent or two antiplatelet agents and the risk of bleeding in haemodialysis patients in 7 RCTs; c. Subgroup analysis of aspirin monotherapy and the risk of bleeding in haemodialysis patientsBack to article page